Le Lézard
Classified in: Health
Subjects: HSP, ASI, LBR, BLK, NTA, AVO, FVT

OPSEU Workers of Colour Caucus forum to tackle health inequity


TORONTO, Feb. 23, 2018 /CNW/ - A forum discussion organized by OPSEU's Workers of Colour Caucus will tackle one of the most pressing issues facing the country today: health inequity.

"Black and racialized Canadians are much more likely to suffer debilitating and deadly diseases than white Canadians," says Peter Thompson, the chair of OPSEU's Workers of Colour Caucus. "This is a profound injustice. Until we confront this injustice, we can never have full equality."

Coinciding with Black History Month and the UN's International Decade for People of African Descent, the "Promoting Health Equity in Racialized Communities" forum is taking place on Friday, Feb. 23, from 6 pm to 9 pm at 31 Wellesley St. East in Toronto. It will feature three expert speakers:

The speakers will detail the ways in which health inequity hurts racialized communities, and consequently all Canadians. The speakers will also lead a discussion exploring possible solutions, which include reducing precarious work and increasing wage equity.

"We have a responsibility to ensure that every person in this province has what they need to live healthy and contented lives," says OPSEU President Warren (Smokey) Thomas. "That includes having a good, stable job with reasonable pay and benefits.

"I'm incredibly grateful that OPSEU's Workers of Colour Caucus is helping lead the fight for health equity in racialized communities. It's a fight that, together, we're going to win."

SOURCE Ontario Public Service Employees Union (OPSEU)


These press releases may also interest you

at 08:05
Gilead Sciences, Inc. today announced the U.S. Food and Drug Administration (FDA) approved an updated label with additional data reinforcing the safety and efficacy profile of Biktarvy® (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide...

at 08:05
Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (MDNAF: OTCQB), a clinical-stage immunotherapy company focused on the development of engineered cytokines, today announced a CA$20 million investment by RA Capital Management, a multi-stage...

at 08:02
Sobi® today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has issued a positive opinion recommending approval of efanesoctocog alfa, for the treatment and prevention of bleeds and perioperative...

at 08:00
Citius Pharmaceuticals Inc. ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, today announced that it has entered into definitive...

at 08:00
Florida Cancer Specialists & Research Institute, LLC (FCS) President & Managing Physician Lucio N. Gordan, MD will serve as a panelist at the 2024 Oncology Fellows & Faculty Forum in Miami, sponsored by PrecisCa and the Community Oncology Alliance...

at 08:00
Renibus Therapeutics® ("Renibus"), a clinical-stage biopharmaceutical company focusing on the prevention and treatment of cardio, renal and metabolic diseases, today announced its participation at two prestigious medical conferences: the American...



News published on and distributed by: